Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
Holding EVH?
Track your performance easily
EVH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.98 - $35.00
Previous Close$23.94
Volume1.43M
Average Volume (3M)2.26M
Market Cap
$2.71B
Enterprise Value$3.32B
Total Cash (Recent Filing)$101.25M
Total Debt (Recent Filing)$635.71M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Nov 07, 2024EPS Estimate
$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.94
Shares Outstanding116,290,379
10 Day Avg. Volume1,451,053
30 Day Avg. Volume2,257,904
Standard Deviation0.18
R-Squared0.20
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)2.64
Price to Sales (P/S)1.18
Price to Cash Flow (P/CF)32.50
P/FCF Ratio48.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.41
Enterprise Value/Gross Profit7.21
Enterprise Value/Ebitda-9.76
Forecast
1Y Price Target
$41.91Price Target Upside79.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Evolent Health News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceEvolent Health Inc. reiterated its $300M adjusted EBITDA run rate target, dispelling concerns of higher prevalence and acuity driving further guidance cuts.
Mergers And AcquisitionsShares of EVH are trading up due to an article in Reuters, stating that several private equity firms, and at least one large health plan, are in discussions to potentially acquire EVH.
Revenue GrowthEVH successfully negotiated rate increases for a few contracts in certain markets that are seeing higher-than-expected medical costs, and it expects the new rates to contribute ~$60M of additional revenue on an annualized basis.
Bears Say
EarningsThe adjusted EBITDA fell short of both internal and market expectations, indicating potential issues with the company's financial performance.
Research And Development CostsThe acquisition of Machinify has led to an increase in research and development expenses, which may pressure overall profitability.
Revenue GuidanceRevenue guidance for the third quarter came in lower than expected, influenced by adjustments related to exiting certain markets, which may impact future earnings.
---
Ownership Overview
1.30% Insiders
42.27% Mutual Funds
1.75% Other Institutional Investors
39.82% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $17.98 and its highest was $35.00 in the past 12 months.
What is Evolent Health’s market cap?
Currently, no data Available
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Nov 07, 2024 which is in 17 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Aug 08, 2024. The company reported $0.3 earnings per share for the quarter, beating the consensus estimate of $0.239 by $0.061.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is $0.29.
How many shares outstanding does Evolent Health have?
Evolent Health has 116,290,380 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of $0.3 in its last earnings report, beating expectations of $0.239. Following the earnings report the stock price went up 26.497%.
Which hedge fund is a major shareholder of Evolent Health?
Among the largest hedge funds holding Evolent Health’s share is RA Capital Management. It holds Evolent Health’s shares valued at 163M.
---
Evolent Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$41.91 (79.87% Upside)
$41.91 (79.87% Upside)
Blogger Sentiment
Bullish
EVH Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.4%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.41%
12-Months-Change
Fundamentals
Return on Equity
-6.93%
Trailing 12-Months
Asset Growth
-6.49%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health, Inc. engages in the provision of health care delivery and payment services. Its solutions include population health management, health plan administration and third party administration, network performance management, risk adjustment, pharmacy benefit management, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services segment and True Health segment. The Services segment includes three types of services designed to help partners manage patient health; value-based care services, specialty care management services and comprehensive health plan administration services. The True Health segment, which operates a health plan in New Mexico, and provides reinsurance to NMHC, takes on certain insurance and underwriting costs in pricing its premiums. The company was founded by Frank J. Williams, Seth B. Blackley, and Tom Peterson in August 2011 and is headquartered in Arlington, VA.
---
EVH Company Deck
---
EVH Earnings Call
Q2 2024
0:00 / 0:00
---
EVH Stock 12 Month Forecast
Average Price Target
$41.91
▲(79.87% Upside)
Technical Analysis
Best Analysts Covering EVH
1 Year
1 Year Success Rate
21/45 ratings generated profit
1 Year Average Return
+18.78%
reiterated a buy rating 2 months ago
Copying Richard Close's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of +18.78% per trade.
---